The Therapeutic Goods Administration is “assessing an application” from Pfizer to register its COVID-19 vaccine for use in children aged 12 to 15. The vaccine is only approved for use for those 16 and older in Australia, but in the US, UK and Canada, children aged 12 and up are already receiving them.